(2020). Tocilizumab for severe COVID-19 related illness – A community academic medical center experience.
Chicago Style (17th ed.) CitationTocilizumab for Severe COVID-19 Related Illness – A Community Academic Medical Center Experience. 2020.
MLA (8th ed.) CitationTocilizumab for Severe COVID-19 Related Illness – A Community Academic Medical Center Experience. 2020.
Warning: These citations may not always be 100% accurate.